No results for ‘’
Solara Active Pharma Sciences Ltd
NSE: SOLARA BSE: 541540
₹565.25
(1.46%)
Wed, 27 May 2026, 05:40 pm
Market Cap27.69B
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KCompany History
2017
- The company was originally incorporated as SSL Pharma Sciences Limited under the Companies Act, 2013.
- The company's name was changed to Solara Active Pharma Sciences Limited and a fresh certificate of incorporation was issued by the RoC.
2019
- Solara Active Pharma Sciences successfully completed the US FDA inspection at the multi-product manufacturing facility at Cuddalore with zero 483s.
2021
- Solara Active Pharma approved the acquisition of the balance 10.77% stake in Sequent Penems.
2023
- Solara Active Pharma Sciences completed the WHO inspection at its Cuddalore facility.
2024
- The company issued rights shares of Rs. 10 in the ratio of 1:3 at a premium of Rs. 365 per share.